P Cianciulli

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

A. Pepe, Antonella Meloni, Marcello Capra et al. · Haematologica · 2010 · 145 citations · Full text

Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study

L Scalone, LG Mantovani, Marieke Krol et al. · Current Medical Research and Opinion · 2008 · 104 citations

PADGEM/GMP‐140 expression on platelet membranes from homozygous beta thalassaemic patients

Domenico Del Principe, Adriana Menichelli, Stefano Di Giulio et al. · British Journal of Haematology · 1993 · 54 citations

Hyperlipidemia, Platelet Selectin Padgem/gmp-140, Inflammation +22

Incidence and clinical study of ectopic erythropoiesis in adult patients with thalassemia intermedia.

P Cianciulli, S Rovasio, L Oggiano et al. · PubMed · 1993 · 45 citations

Anemia, Immunohematology, Ee Development +14

Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function.

Maria Grazia Marciani, P Cianciulli, N. Stefani et al. · PubMed · 1991 · 32 citations